|
|
| Médicaments En Vente Libre > Etude de marché sectorielle |
| The World Generics Market 2006-2011 |
|
|
|
|
€ 2 219,00 |
Editeur
: |
Visiongain |
Langue
: |
Anglais |
Date de publication : |
Mai 2006 |
Taille du document : |
143 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
Documents Publics |
1,200,000
documents |
Téléchargement illimités |
|
|
|
Etudes Privées |
50,000 rapports et études |
Paiement à la piéce |
|
|
|
|
| |
|
1.Télécharger nos rapports publics
Accés complet à plus de 1,2 Million de documents publics : études de marché, statistiques sectorielles, fiches pays, monographie d'entreprises, veille concurentielle, rapports annuels...
|
| Nos documents publics sur le même théme (2) |
|
|
|
| 55 pages | Décembre 2003 | Anglais
|
|
|
| Main
focus: |
pharmaceutical,therapeutic classes,pharmaceuticals,...,...
|
| Research
focus: |
market size and estimates,market outlook, |
| Geographic
focus: |
usa,canada,india,china,mexico,japan,philippines,... |
| |
|
|
|
|
| 47 pages | Mai 2007 | Anglais
|
|
|
| Main
focus: |
generics,pharmaceutical,pharmaceuticals,...
|
| Research
focus: |
market size and estimates,market outlook, |
| Geographic
focus: |
usa,germany,canada,france,united kingdom,italy,... |
| |
|
|
|
|
| Autres recherches sur le même thème |
|
|
|
| |
| |
|
| |
|
2.
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
The Biogenerics Market Outlook: An analysis of market dynamics, growth drivers and leading players
87 pages | Mars 2005 |
Branded biologic medicines generated an estimated $32bn of sales for the biotechnology and pharmaceutical industries and represented the fastest growing group of medicines; while continued high demand |
1 520,00 €
|
| |
| |
UK Cough Cold & Throat Remedies 2004
12 pages | Juillet 2004 |
Snapdata's UK Cough Cold & Throat Remedies 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the UK cough, cold an |
240,00 €
|
| |
| |
US Antacids 2004
16 pages | Juillet 2004 |
Snapdata's US Antacids 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US antacid market, and covers antacid |
240,00 €
|
| |
| |
US Lip Remedies 2004
13 pages | Juillet 2004 |
Snapdata's US Lip Remedies 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US lip remedy market, and covers |
240,00 €
|
| |
| |
US Hair Growth Products 2004
12 pages | Juillet 2004 |
Snapdata's US Hair Growth Products 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US hair growth product ma |
240,00 €
|
| |
| |
Poland OTC Pharmaceuticals 2004
11 pages | Juillet 2004 |
Snapdata's Poland OTC Pharmaceuticals 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the Polish OTC pharmaceuti |
240,00 €
|
| |
| |
The Pharmaceutical OTC Market to 2010
130 pages | Février 1999 |
Survey : Datamonitor's survey identifies the role that the OTC market plays within the healthcare environment and the current and future dynamics of the industry in terms of OTC therapies and in |
795,00 €
|
| |
| |
US Smoking Cessation Aids 2004
13 pages | Juillet 2004 |
Snapdata's US Smoking Cessation Aids 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US smoking cessation ai |
240,00 €
|
| |
| |
US Cough Drops & Throat Lozenges 2004
12 pages | Juillet 2004 |
Snapdata's US Cough Drops & Throat Lozenges 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US cough drop an |
240,00 €
|
| |
| |
US Mineral Supplements 2004
12 pages | Novembre 2004 |
Snapdata's US Mineral Supplements 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US mineral supplement mark |
240,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| The World Generics Market 2006-2011 |
|
|
In sharp contrast to the branded pharmaceutical market, which has stalled in recent year, the generics market is enjoying a period of unprecedented success. In 2005 the world generics market was worth $45bn, a growth of 14% on the previous year. Visiongain expects this level of growth to continue over the forecast period of this report.
The loss of patent protection by 2009 of almost $80bn worth of top selling drugs will be the major driving force for this generic market growth. Additionally, as healthcare costs in the developed world continue to increase, and the growth of pharmaceutical markets in developing countries continues to grow. More generic copies of successful drugs are being sold worldwide than ever before. This report describes how this burgeoning market will change over the forecast period and highlights the important issues for both originator companies and generic drugs manufacturers.
What is the therapeutic area with the most potential for generic companies? How are branded pharmaceutical companies preparing for the increasing threat of generic penetration? What challenges do generic companies face in the coming years? Read visiongain's The World Generics Market 2006-2011 report to find out.
The following issues are covered in detail:
A summary of the relevant legislation affecting the generics industry
A market forecast for the world generics market 2006-2011
An assessment of the drivers and restraints of the market during this period
A discussion of the attitudes to generics in different regions including the US, Europe and Asia
The issue of Biogenerics and the changes in regulations required for their success
A review of strategies for success for originator and generics companies
Why should you buy this report?
The progress of the generic pharmaceutical market is of great importance to anyone in the pharmaceutical industry. This report provides detailed financial data and invaluable opinion about how this market will change over the important period to come.
|
|
The World Generics Market 2006-2011
|
|
|
PPLSEN
|
|
|
|
|
